Figure 4.

Viability of cancer cells upon THz irradiation. (A) Proportion of viable cancer cells, derived from Burkitt’s lymphoma (Ramos) and T-cell acute lymphoblastic leukemia (Jurkat), calculated from the original cell concentration, when cell suspensions were irradiated from the surface; (B) as in (A), proportion of viable cancer cells, derived from breast adenocarcinoma (MCF7) and prostate cancer (LNCaP); (C) as in (A), but the cells were irradiated through the bottom of the wells; (D) As in (B), but MCF7 adherent cells were irradiated through the bottom of the wells.